How to use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisions.

Bell, Katy Jl; Stanaway, Fiona F; Irwig, Les M; Horvath, Andrea R; Teixeira-Pinto, Armando; Loy, Clement

Bell, Katy Jl; Stanaway, Fiona F; Irwig, Les M; Horvath, Andrea R; Teixeira-Pinto, Armando; Loy, Clement.

Bell KJ; University of Sydney, Sydney, NSW.
Stanaway FF; University of Sydney, Sydney, NSW.
Irwig LM; University of Sydney, Sydney, NSW.
Horvath AR; Prince of Wales Hospital and Community Health Services, Sydney, NSW.
Teixeira-Pinto A; University of Sydney, Sydney, NSW.
Loy C; Centre for Kidney Research, Westmead Millennium Institute for Medical Research, Sydney, NSW.

Med J Aust ; 214(2): 69-73.e1, 2021 02.

Article in English | MEDLINE | ID: covidwho-1013502

Subject(s)

COVID-19 Testing/standards; COVID-19/diagnosis; Clinical Decision-Making; Humans; Medical History Taking; SARS-CoV-2; Sensitivity and Specificity

Keywords

COVID-19; Diagnostic tests and procedures; Evidence-based medicine; Infectious diseases; Respiratory tract infections

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Decision-Making / COVID-19 Testing / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Med J Aust Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google